Showing results (71-80 of 93) with videos related to
Sort By:
Pageof 10
NPJ Breast Cancer|January 12, 2022
Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancerSherene Loi, Roberto Salgado, Sylvia Adams, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 17, 2019
Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast CancersSherene Loi, Damien Drubay, Sylvia Adams, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2013
Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical OncologyJyoti D Patel, Lada Krilov, Sylvia Adams, et al.JCO Precision Oncology|April 26, 2023
Association Between Biomarkers and Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Metastatic Triple-Negative Breast Cancer: KEYNOTE-086 Exploratory AnalysisSherene Loi, Roberto Salgado, Peter Schmid, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2011
Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical OncologyNicholas J Vogelzang, Steven I Benowitz, Sylvia Adams, et al.Cancer Immunology Research|January 31, 2015
Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with high-risk melanomaRachel Lubong Sabado, Anna Pavlick, Sacha Gnjatic, et al.Cancer Discovery|December 16, 2021
Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast CancerChewei Anderson Chang, Jayu Jen, Shaowen Jiang, et al.NPJ Breast Cancer|October 12, 2019
Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancerDavid B Page, Harry Bear, Sangeetha Prabhakaran, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2008
Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvantSylvia Adams, David W O'Neill, Daisuke Nonaka, et al.JAMA Oncology|April 12, 2019
Current Landscape of Immunotherapy in Breast Cancer: A ReviewSylvia Adams, Margaret E Gatti-Mays, Kevin Kalinsky, et al.Pageof 10